Genomma Lab Advances in Mexico as Third-Quarter Profit Improves

Genomma Lab Internacional SAB, a Mexican producer of over-the-counter drugs, jumped the most in three weeks after a report showed profits and sales jumped in the third quarter and a measure of cash generation improved.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.